Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer

There is a lack of direct cross-comparison studies in clinical trials between immunotherapy alone and combination treatment, especially in Non-Small Cell Lung Cancer (NSCLC) patients with high PD-L1 expression. To determine if anti-PD-(L)1 antibody combined with chemotherapy is more efficient than i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue, Niu, Xiaomin, An, Na, Sun, Yile, Chen, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013714/
https://www.ncbi.nlm.nih.gov/pubmed/33816241
http://dx.doi.org/10.3389/fonc.2021.611012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013714/
https://www.ncbi.nlm.nih.gov/pubmed/33816241
http://dx.doi.org/10.3389/fonc.2021.611012

Ejemplares similares